Just published! “The Cost-Effectiveness of a Novel Online Social Therapy to Maintain Treatment Effects From First-Episode Psychosis Services: Results From the Horyzons Randomized Controlled Trial”
Shalini Lal
Défilez la page pour la version française | Scroll down for French text
Check out this recent publication! Our collaborators from the Orygen team, along with our YMHtech director Dr. Shalini Lal, published an article titled “The Cost-Effectiveness of a Novel Online Social Therapy to Maintain Treatment Effects From First-Episode Psychosis Services: Results From the Horyzons Randomized Controlled Trial” in the Schizophrenia Bulletin Journal.
To read more about the study, click the following link: https://doi.org/10.1093/schbul/sbad071
Consultez cette récente publication ! Nos collaborateurs de l'équipe Orygen, ainsi que la directrice de laboratoire YMHtech, la Dre. Shalini Lal, ont publié un article intitulé "The Cost-Effectiveness of a Novel Online Social Therapy to Maintain Treatment Effects From First-Episode Psychosis Services : Results From the Horyzons Randomized Controlled Trial" dans le journal Schizophrenia Bulletin.
Pour en savoir plus sur cette étude, cliquez sur le lien suivant : https://doi.org/10.1093/schbul/sbad071